228 related articles for article (PubMed ID: 35604217)
1. Irreversible Loss of HIV-1 Proviral Competence in Myeloid Cells upon Suppression of NF-κB Activity.
Peters RJ; Stevenson M
J Virol; 2022 Jun; 96(12):e0048422. PubMed ID: 35604217
[TBL] [Abstract][Full Text] [Related]
2. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
[TBL] [Abstract][Full Text] [Related]
3. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
4. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
[TBL] [Abstract][Full Text] [Related]
5. Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.
Abreu CM; Veenhuis RT; Avalos CR; Graham S; Parrilla DR; Ferreira EA; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Mac Gabhann F; O'Connor SL; Gama L; Clements JE
mBio; 2019 Aug; 10(4):. PubMed ID: 31431552
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of Latency Establishment in the Different Human CD4
Butta GM; Bozzi G; Gallo G; Copaloni G; Cordiglieri C; Crosti M; Mancino M; Prati D; Simon V; Gori A; Bandera A; De Francesco R; Manganaro L
J Virol; 2022 May; 96(10):e0037922. PubMed ID: 35499323
[TBL] [Abstract][Full Text] [Related]
7. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.
Wang X; Xu H
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670027
[TBL] [Abstract][Full Text] [Related]
8. Bryostatin-1 Decreases HIV-1 Infection and Viral Production in Human Primary Macrophages.
Hany L; Turmel MO; Barat C; Ouellet M; Tremblay MJ
J Virol; 2022 Feb; 96(4):e0195321. PubMed ID: 34878918
[TBL] [Abstract][Full Text] [Related]
9. SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.
Dashti A; Waller C; Mavigner M; Schoof N; Bar KJ; Shaw GM; Vanderford TH; Liang S; Lifson JD; Dunham RM; Ferrari G; Tuyishime M; Lam CK; Nordstrom JL; Margolis DM; Silvestri G; Chahroudi A
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817214
[TBL] [Abstract][Full Text] [Related]
10. Modeling HIV-1 Latency Using Primary CD4
Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
[TBL] [Abstract][Full Text] [Related]
11. New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir.
Patro SC; Niyongabo A; Maldarelli F; Kearney MF
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960744
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Latency and Eradication: Past, Present and Future.
Datta PK; Kaminski R; Hu W; Pirrone V; Sullivan NT; Nonnemacher MR; Dampier W; Wigdahl B; Khalili K
Curr HIV Res; 2016; 14(5):431-441. PubMed ID: 27009094
[TBL] [Abstract][Full Text] [Related]
13. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies.
Khanal S; Schank M; El Gazzar M; Moorman JP; Yao ZQ
Cells; 2021 Feb; 10(2):. PubMed ID: 33672138
[TBL] [Abstract][Full Text] [Related]
15. The cell biology of HIV-1 latency and rebound.
Mbonye U; Karn J
Retrovirology; 2024 Apr; 21(1):6. PubMed ID: 38580979
[TBL] [Abstract][Full Text] [Related]
16. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
17. Development of a Novel
Wong ME; Johnson CJ; Hearps AC; Jaworowski A
J Virol; 2021 Sep; 95(19):e0022721. PubMed ID: 34287050
[TBL] [Abstract][Full Text] [Related]
18. Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques.
McBrien JB; Wong AKH; White E; Carnathan DG; Lee JH; Safrit JT; Vanderford TH; Paiardini M; Chahroudi A; Silvestri G
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669328
[TBL] [Abstract][Full Text] [Related]
19. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators.
; ; . PubMed ID: 31413127
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
